- Home
- NVAX vs AHR Comparison
NVAX vs AHR Comparison
Compare NVAX & AHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- AHR
- Stock Information
- Founded
- NVAX 1987
- AHR 2013
- Country
- NVAX United States
- AHR United States
- Employees
- NVAX N/A
- AHR N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- AHR
- Sector
- NVAX Health Care
- AHR
- Exchange
- NVAX Nasdaq
- AHR NYSE
- Market Cap
- NVAX 1.3B
- AHR 5.2B
- IPO Year
- NVAX 1995
- AHR 2024
- Fundamental
- Price
- NVAX $6.80
- AHR $37.30
- Analyst Decision
- NVAX Buy
- AHR Strong Buy
- Analyst Count
- NVAX 5
- AHR 8
- Target Price
- NVAX $16.60
- AHR $37.75
- AVG Volume (30 Days)
- NVAX 5.2M
- AHR 2.0M
- Earning Date
- NVAX 08-07-2025
- AHR 08-07-2025
- Dividend Yield
- NVAX N/A
- AHR 2.70%
- EPS Growth
- NVAX N/A
- AHR N/A
- EPS
- NVAX 2.97
- AHR N/A
- Revenue
- NVAX $1,254,962,000.00
- AHR $2,104,227,000.00
- Revenue This Year
- NVAX $56.85
- AHR $8.10
- Revenue Next Year
- NVAX N/A
- AHR $6.50
- P/E Ratio
- NVAX $2.29
- AHR N/A
- Revenue Growth
- NVAX 25.92
- AHR 10.53
- 52 Week Low
- NVAX $5.01
- AHR $14.79
- 52 Week High
- NVAX $17.81
- AHR $37.25
- Technical
- Relative Strength Index (RSI)
- NVAX 51.68
- AHR 66.23
- Support Level
- NVAX $6.23
- AHR $35.70
- Resistance Level
- NVAX $6.90
- AHR $36.85
- Average True Range (ATR)
- NVAX 0.30
- AHR 0.96
- MACD
- NVAX 0.01
- AHR -0.01
- Stochastic Oscillator
- NVAX 67.00
- AHR 92.47
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.